Expanding Excellence in Developmental Biology in Oklahoma
Expanding Excellence in Developmental Biology in Oklahoma
批准号:
10455879
负责人:
Jyoti Iyer
金额:
$15.85万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-01 至 2023-06-30
关键词:
AffectAllelesAnimal ModelBasic ScienceBehavioralBiochemicalBiologicalBiological AssayBiological ProcessCaenorhabditis elegansCellsCentriolesClustered Regularly Interspaced Short Palindromic RepeatsDevelopmental BiologyDiseaseDwarfismGene DuplicationGoalsHumanImpairmentIncidenceMalignant NeoplasmsMicrocephalyMicroscopicMolecularMutationOklahomaPathologicProteinsResearchTestingTherapeutic Interventioncilium biogenesisinnovationinsightpreventive interventionprotein functiontool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mutations in centriole duplication (CD) genes are correlated with the incidence of diseases such as primary
microcephaly, primordial dwarfism and cancer. However, the effect of many of these disease-associated
mutations in CD genes on their respective protein functions is currently unknown. This proposal utilizes one
such disease-associated mutation in the conserved CD gene Spindle Assembly Abnormal Protein 6
(HsSAS-6/ SAS-6) as a tool to study SAS-6 function in ciliogenesis and CD. This disease-relevant HsSAS-
6 mutation is associated with the incidence of primary microcephaly and corresponds to sas-6(L69T) in C.
elegans. Our long-term goal is to exploit disease-associated alleles of conserved CD genes to better
understand their mechanism of action in regulating ciliogenesis and CD. The overall objectives in this
application are to determine the effect of the sas-6(L69T) mutation on C. elegans ciliogenesis and CD. The
central hypothesis is that the sas-6(L69T) mutation inhibits SAS-6 function leading to impaired ciliogenesis
and CD. The rationale for this project is that since this mutation has a known pathological consequence in
humans, it will provide important insights into the normal biological function of SAS-6. The central
hypothesis will be tested by pursuing two specific aims: 1) Determine the effect of the sas-6(L69T) mutation
on C. elegans ciliogenesis; 2) Elucidate the molecular mechanism by which the sas-6(L69T) mutation
impairs CD in C. elegans. Under the first aim, the consequences of the sas-6(L69T) mutation on C. elegans
ciliogenesis will be determined by performing a thorough microscopic and behavioral analysis of a C.
elegans CRISPR strain carrying this mutation. In the second aim, a variety of cell biological and
biochemical assays will be performed to clarify the molecular mechanism by which this mutation affects
CD. The research proposed in the application is innovative because i) This is the first study investigating
the effects of a primary-microcephaly-associated sas-6 mutation in a multicellular eukaryotic animal model.
ii) This is the first study that uses a disease-associated sas-6 allele to study SAS-6 function in regulating
ciliogenesis. Developing therapeutic or preventative interventions for any disease begins with
understanding the fundamental consequences of disease-associated mutations at the level of basic
science. The proposed research is significant because there is currently nothing known about the
mechanistic effects of this primary microcephaly-associated sas-6 mutation. Understanding the cellular and
biochemical consequences of the sas-6(L69T) mutation is the first important step to understanding the
mechanism of incidence and progression of primary microcephaly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expanding Excellence in Developmental Biology in Oklahoma
-
批准号:10474315
-
项目类别:
-
资助金额:$15.98万
-
财政年份:2013
-
负责人:Jyoti Iyer
-
依托单位:
海外基金